Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-12-19
pubmed:abstractText
Interleukin 6 (IL-6) is a growth and survival factor for multiple myeloma cells. As we report here, the IL-6-dependent human myeloma cell line INA-6 responds with a remarkably rapid and complete apoptosis to cytokine withdrawal. Among the antiapoptotic members of the B-cell lymphoma-2 (Bcl-2) family of apoptosis regulators, only myeloid cell factor-1 (Mcl-1) was slightly induced by IL-6. Overexpression studies demonstrated, however, that IL-6 does not exert its survival effect primarily through this pathway. The IL-6 signal transduction pathways required for survival and the target genes controlled by them were analyzed by using mutated receptor chimeras. The activation of signal transducer and activator of transcription 3 (Stat3) turned out to be obligatory for the survival of INA-6 cells. The same held true for survival and growth of XG-1 myeloma cells. Gene expression profiling of INA-6 cells by using oligonucleotide microarrays revealed many novel IL-6 target genes, among them several genes coding for transcriptional regulators involved in B-lymphocyte differentiation as well as for growth factors and receptors potentially implicated in autocrine or paracrine growth control. Regulation of most IL-6 target genes required the activation of Stat3, underscoring its central role for IL-6 signal transduction. Taken together, our data provide evidence for the existence of an as yet unknown Stat3-dependent survival pathway in myeloma cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Cytokine Receptor gp130, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/IL6ST protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Erythropoietin, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/STAT3 Transcription Factor, http://linkedlifedata.com/resource/pubmed/chemical/STAT3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
242-51
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12969979-Antigens, CD, pubmed-meshheading:12969979-Apoptosis, pubmed-meshheading:12969979-Base Sequence, pubmed-meshheading:12969979-Cell Division, pubmed-meshheading:12969979-Cell Line, Tumor, pubmed-meshheading:12969979-Cell Survival, pubmed-meshheading:12969979-Cytokine Receptor gp130, pubmed-meshheading:12969979-DNA, Neoplasm, pubmed-meshheading:12969979-DNA-Binding Proteins, pubmed-meshheading:12969979-Gene Expression Profiling, pubmed-meshheading:12969979-Genes, bcl-2, pubmed-meshheading:12969979-Humans, pubmed-meshheading:12969979-Interleukin-6, pubmed-meshheading:12969979-Membrane Glycoproteins, pubmed-meshheading:12969979-Multiple Myeloma, pubmed-meshheading:12969979-Mutation, pubmed-meshheading:12969979-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:12969979-Receptors, Erythropoietin, pubmed-meshheading:12969979-Recombinant Proteins, pubmed-meshheading:12969979-STAT3 Transcription Factor, pubmed-meshheading:12969979-Signal Transduction, pubmed-meshheading:12969979-Trans-Activators
pubmed:year
2004
pubmed:articleTitle
Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.
pubmed:affiliation
Institute of Clinical Immunology and Transfusion Medicine, University Hospital Leipzig, Johannisallee 30, 04103 Leipzig, Germany. fhorn@medizin.uni-leipzig.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't